Chartwell Investment Partners’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,220
Closed -$272K 406
2022
Q3
$272K Buy
13,220
+466
+4% +$13K 0.01% 407
2022
Q2
$353K Buy
12,754
+5,786
+83% +$198K 0.01% 407
2022
Q1
$305K Buy
6,968
+291
+4% +$12.6K 0.01% 408
2021
Q4
$369K Sell
6,677
-122
-2% -$7.54K 0.01% 419
2021
Q3
$420K Hold
6,799
0.01% 415
2021
Q2
$578K Buy
6,799
+61
+0.9% +$5.57K 0.02% 403
2021
Q1
$533K Sell
6,738
-362
-5% -$23.5K 0.02% 396
2020
Q4
$413K Buy
+7,100
New +$334K 0.01% 411

Other funds holding AFMD

Chartwell Investment Partners's AFMD Position: Q4 2022 in Review

Chartwell Investment Partners sold out of Affimed (AFMD) in Q4 2022, closing a stake of 13,220 shares — an estimated $272K sold.

Chartwell Investment Partners first reported a position in AFMD in Q4 2020 and held it in 8 quarters. The position peaked at $578K in Q2 2021. 118 funds tracked by Wall St. Rank hold AFMD as of Q4 2022.

  • Chartwell Investment Partners reported no remaining Affimed position as of Q4 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 13,220 Affimed shares in Q4 2022, an estimated $272K.
  • Chartwell Investment Partners first reported a position in Affimed in Q4 2020 and held it in 8 quarters.
  • Chartwell Investment Partners's Affimed position peaked at $578K in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Affimed as of Q4 2022.

Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.